Arthroscopy: The Journal of Arthroscopic and Related Surgery
Article Processing Fees for "Technical Note" articles published in Arthroscopy Techniques
Beginning April 1, 2017, the journal will charge an article processing fee for all Technical Notes upon acceptance for publication in Arthroscopy Techniques, the open access companion to Arthroscopy:
$600 for members of the Arthroscopy Association of North America
$900 for non-members
Beginning January 1, 2021, the article processing fee will increase to:
$700 for members of the Arthroscopy Association of North America
$975 for non-members
INTRODUCTION
All submissions to Arthroscopy: The Journal of Arthroscopic and Related Surgery must comply with these Instructions for Authors. Studies should be in compliance with human studies committees and animal welfare regulations at the authors' institutions and also in compliance with Food and Drug Administration guidelines. All manuscripts will be subject to peer review. Letters to the Editor and comments on the Journal's content or policies are always welcome and encouraged.
All manuscripts are to be submitted electronically through the Arthroscopy online submission and review system website www.editorialmanager.com/arth (details in Submission section below).
SUBMISSION DECLARATION AND AUTHOR WARRANTIES
Submission of a manuscript to Arthroscopy for peer review implies that:
It is original work, has been written by the stated authors, and has not been published elsewhere, including electronically, in the same form, in any language. Likewise, a similar manuscript has not been submitted to or published by any other journal, by any of the authors
Any manuscript submitted to Arthroscopy is not currently being considered for publication by any other journal and will not be submitted for such review while under review by this Journal.
If the submission is accepted, it will not be published elsewhere, including electronically in the same form, in any language, without the written consent of the copyright holder.
BEFORE YOU BEGIN
Disclosure of Potential Conflict of Interest
Arthroscopy uses the ICMJE disclosure for authors. Each author of a manuscript must complete the form and save it using his or her name. The corresponding author will upload all the authors' completed forms at the time of submission. Download the Arthroscopy Journal ICMJE form here: ICMJE Form
In order to combine the "Fillable PDF" ICMJE disclosure forms from each author of your article, you will first need to "print" each form as "Adobe PDF" which will reformat the form, enabling it to be combined with other forms. To accomplish this, click File, then Print, then select "Adobe PDF" from the printer drop down menu, and click Print. Then save the file to your computer. Once all author forms are saved in this format, you will be able to combine the files.
An easy method to combine files is to select all of the disclosure forms to be combined in the folder where they are stored, right-click, and select "Combine supported files in Acrobat."
Authorship
Arthroscopy generally limits the number of authors to 7. If there are more than 7 authors, we ask the corresponding author to justify each author's participation using the ICMJE criteria for authorship:
Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
Drafting the work or revising it critically for important intellectual content; AND
Final approval of the version to be published; AND
Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Copyright
Copyright to all published articles will be held by the Arthroscopy Association of North America. Copyright forms are handled by the production department of the publisher once a manuscript is accepted and scheduled for publication.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Registration of Clinical Trials
Clinical trial registration (prospective publication of clinical research study authors, title, purpose, hypothesis, methods including statistical methods, and confirmation of Institutional Review Board approval) mitigates against bias resulting from selective reporting of results. Clinical trials beginning patient enrollment after January 1, 2012, will not be accepted for publication in Arthroscopy without prospective registration of the trial (i.e., before enrollment of the first patient). Trials may be registered in any national or international registry. Include details on the separate title page only.
Except in rare circumstances where the temporal effect of the outcome being measured is brief, clinical trials will not be accepted for publication in Arthroscopy without 24 months' minimum follow-up for all subjects who are enrolled and reported. The Journal strongly encourages the use of the CONSORT (Consolidated Standards of Reporting Trials) guidelines when designing and reporting randomized controlled trials (RCTs). The criteria outlined by the CONSORT group are meant to assist in improving the overall quality of RCTs, and provides a minimum set of recommendations for reporting on RCTs. There is a 25-item checklist designed to facilitate study setup, reporting, and interpretation. The overall goal of using the CONSORT criteria is to facilitate the study design from the outset, and provide for a high-quality and prudently conceived RCT. The guidelines can be found at http://www.consort-statement.org/Media/Default/Downloads/CONSORT%202010%20Checklist.doc.
SUBMISSION
After registering as an author through the Arthroscopy online submission and review system website (www.editorialmanager.com/arth), you will be guided step by step through the uploading of your own files and approving of the single PDF that will be created from them. You can track the progress of your manuscript through our website. Communications about a manuscript will be handled through e-mail. Please access the website for more specifics about online submission, including a tutorial for authors, artwork guidelines, and a link to author support by e-mail that is monitored around the clock.
PREPARATION
Peer Review
This journal operates a double blind review process, which means the identities of the authors are concealed from the reviewers, and vice versa. All contributions are typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. More information on types of peer review.
General
Manuscripts should be typed double-spaced with continuous line numbering. Submit in this order; see details in the following sections: Separate (unblinded) title page, blinded title page, blinded text, references, figure and video legends, tables, figures, and conflict of interest forms. Arthroscopy follows style points for text and references of the AMA Manual of Style.
Recommended Maximums for Articles Submitted to Arthroscopy
Type of Article
Number of Words*
Figures (Figure Parts)
Tables
Original Article 4,000 7 (15) 4
Level V Evidence† 1,600 0 0
Systematic Review 4,500 7 (15) 4
Meta-analysis 4,000 7 (15) 4
Technical Note‡ 1,500‡ no limit‡ 4
Case Report (rarely accepted) — — —
Letter to Editor & Reply 500 2 (2) 0
* Maximum number of words is exclusive of the title page, blind title page, references, and figure legends.
† Level V Evidence articles are submitted at the invitation of the Editor-in-Chief or Assistant Editor-in-Chief.
‡ Technical Notes are now published only in Arthroscopy Techniques. Video is required for submission. The video must be narrated and list disclosures on an opening slide. Submit as for Arthroscopy at www.editorialmanager.com/arth
Separate Title Page
A separate (unblinded) title page of each manuscript should include the following essential information:
Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
All Authors' full names, degrees, and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present each author's affiliation and address below the names.
Corresponding Author. Clearly indicate who will handle correspondence at all stages of reviewing and publication, and after publication. Ensure that telephone numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.
In addition, include IRB and RCT information, as well as a short running title (maximum of 45 characters and spaces). Include any acknowledgment of persons who provided help during the research/writing (e.g., language help, writing assistance, or proof reading the manuscript, etc.).
Blinding the Manuscript
Because all manuscripts are blinded to reviewers, the first page of the blinded manuscript must be a blinded title page that lists only the title. Likewise, in the text, do not include any identifying information, such as an author's initials or the names of institutions where the study was done, or a phrase such as "our study" that, when followed by a citation, reveals authorship of the present manuscript in the reference list.
Manuscript Structure
1. Abstract
Original Articles, abstracts should be a maximum of 300 words and structured to include the following sections: Purpose: One or 2 sentences that simply state the purpose with no background information or hypothesis. Methods: Provide, with sufficient detail, the methods of the study including selection criteria. Results: Provide results, with data, P values, and standard deviation of mean or 95% confidence intervals. Present most important findings first. Please provide exact P values (not P <) and numbers to support your methods findings. Conclusions: State only what your study found; do not include extraneous information not backed up by the results. Level of Evidence (for human studies) or Clinical Relevance (basic science or in vitro study: why is this study important from a clinical standpoint?).
Systematic Reviews and Meta-analyses, the abstract and text should be structured as an Original Article.
Technical Notes for Arthroscopy Techniques, the abstract should be an unstructured summary (maximum length, 200 words). The body of these manuscripts should consist of unstructured summary abstract, Introduction, Technique, and Discussion, plus references and figure legends and video legend.
Case Reports, the text should consist of unstructured summary abstract, Introduction, Case Report, and Discussion, plus references and figure legends.
Level V Evidence articles, the abstract should be an unstructured summary (maximum length, 300 words). See the Levels of Evidence table.
2. Introduction
The introduction of an Original Article should succinctly state the problem or controversy that led you to undertake the study, including a concise review of only the most relevant literature. Conclude the introduction by stating the purpose of the study and your hypothesis. The purpose in the Introduction should match that of the Abstract.
3. Methods
Describe the study design (prospective or retrospective, inclusion and exclusion criteria, duration). If prospective or a cadaver study, the number of enrolled subjects is reported in Methods. If retrospective, the study population (numbers, demographics, length of follow-up) should be in Results.
Include IRB and animal studies information. IRB approval is required for all human studies except retrospective and cadaver studies (unless the institution where the study was performed requires it).
The statistics that you have used to analyze the data should be described in detail. You cannot make the statement, "We found no significant difference between the two groups" unless a power study was done and you include in the text the value of alpha, beta, and standard deviation. Use of the word significant requires your reporting an exact P value. Confidence intervals of 95% are required whenever the results of survivorship analysis are given in the text, tables, or figures. Use of the word correlation requires you to report the correlation coefficient.
Arthroscopy encourages the use of validated outcome instruments. The use of both a general health outcome measure and a joint-specific, limb-specific, or condition-specific measure is encouraged. If an outcome instrument leads to a categorical ranking (e.g., excellent or good or poor), the aggregate outcome score for each patient should be provided.
4. Results
Describe in detail the data obtained during the study following the order of the Methods to include final number of subjects, demographics, length of follow-up (mean and range). The overall final patient follow-up should be 80% or greater (less than 20% drop-out) in order to minimize follow-up bias. In general, scientific studies will not be accepted for publication without meeting this criterion. Results obtained with less than two years of follow-up are rarely accepted for publication by the Journal. All data in the text must be consistent with the rest of the manuscript, including data in tables, figures, and legends. Present comparison data in tables and present as mean ± standard error of the mean with confidence intervals.
5. Discussion
Be concise. The Discussion should start with the most important findings of your study. Is your hypothesis affirmed or refuted? Compare and contrast your study with others in the most relevant world literature, particularly the recent literature. A complete literature review is unnecessary.
At the end of the Discussion, under the subheading "Limitations," review the limitations of your study.
……
更多详情：
https://www.arthroscopyjournal.org/content/authorinfo
